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Abstract
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The etiology of autism spectrum disorder (ASD) is multifactorial and complex and likely involves
interactions among genetic, epigenetic and environmental factors. With respect to environmental
influences, a growing literature implicates intrauterine experiences in the origin of this pervasive
developmental disorder. In this prospective longitudinal design, we examine the hypothesis that
fetal exposure to maternal cortisol may confer ASD risk. In addition, because ASD is four times
more prevalent in males than females and because sexually dimorphic responses to intrauterine
experiences are commonly observed, we examine whether or not any associations differ by fetal
sex. Maternal plasma cortisol was measured at 15, 19, 25, 31, and 37 weeks’ gestation in a sample
of 84 pregnant women. ASD symptoms were assessed in their 5-year old children with the Social
Communication Questionnaire (SCQ). Fetal exposure to lower levels of maternal cortisol was
associated with higher levels of ASD symptoms among boys only. The observed hypocortisolemic
profile exhibited by these mothers may indicate a risk factor that precedes the stress of caregiving
for a child with ASD and may not be solely a consequence of the stress of caregiving as previously
thought. Further, these findings confirm the value of examining prenatal hormone exposures as
predictors of ASD risk and support the premise that altered prenatal steroid exposures may play a
role in the etiology of ASD.
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The Centers for Disease Control and Prevention (CDC) estimates that 1 in 68 children has
been identified with Autism Spectrum Disorder (ASD), a developmental disability
characterized by social and communication impairments and repetitive or restricted
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behaviors and interests (American Psychiatric Association, 2013; Centers for Disease
Control and Prevention, 2014). ASD is common in all racial, ethnic, and socioeconomic
groups, and evidence suggests that autism symptoms are continuously distributed across the
population (Baron-Cohen, Wheelwright, Skinner, Martin, & Clubley, 2001; Constantino &
Todd, 2003; Mulligan, Richardson, Anney, & Gill, 2009; Posserud, Lundervold, & Gillberg,
2006; Spiker, Lotspeich, Dimiceli, Myers, & Risch, 2002). Although significant advances
have been made in identifying genetic contributions to this disorder (Abrahams &
Geschwind, 2008; Hallmayer et al., 2011; Risch et al., 2014; Robinson, Neale, & Hyman,
2015; Sebat et al., 2007; Trottier, Srivastava, & Walker, 1999), there also is accumulating
support for significant non-genetic or environmental influences (Durkin et al., 2008; Janecka
et al., 2017; Lai, Lombardo, & Baron-Cohen, 2014; Landrigan, 2010) and for gene x
environment interactions (Abbott, Gumusoglu, Bittle, Beversdorf, & Stevens, 2018; Hecht et
al., 2016; Schaafsma et al., 2017; Tordjman et al., 2014). Among these environmental
influences, a growing literature implicates intrauterine experiences in the etiology of ASD,
including obstetric complications and adverse birth phenotype (Atladottir et al., 2010;
Schendel & Bhasin, 2008), prenatal steroid profiles (Baron-Cohen et al., 2015; Knickmeyer
& Baron-Cohen, 2006) and prenatal stress exposures (Beversdorf et al., 2005; Class et al.,
2014; Jones et al., 2010; Kinney, Munir, Crowley, & Miller, 2008; Rodriguez & Bohlin,
2005; Sjaarda et al., 2017; Varcin, Alvares, Uljarevic, & Whitehouse, 2017).

A Potential Role Prenatal Cortisol Exposures in ASD

Author Manuscript

Here we examine the hypothesis that fetal exposure to maternal cortisol may confer ASD
risk (Gitau, Adams, Fisk, & Glover, 2005; Gore, Martien, Gagnidze, & Pfaff, 2014;
Matthews, 2000; Rose’meyer, 2013; Rose’meyer, 2014; Whitaker-Azmitia, Lobel, & Moyer,
2014). The plausibility of this hypothesis is supported not only by the documentation of
links between intrauterine stress exposures and ASD risk described above, but also because
cortisol (the primary glucocorticoid (GC) in humans) has been implicated broadly as a
principal effector of fetal programming due to its critical role in fetal organ and brain
development and the fact that it is modulated by stress exposures and environmental
conditions (Moisiadis & Matthews, 2014; Sandman & Glynn, 2009; Sarkar, Bergman,
O’Connor, & Glover, 2008; Seckl, 2004; Welberg & Seckl, 2001).
Cortisol in human pregnancy.

Author Manuscript

Cortisol is a steroid hormone that plays a critical role in normal development and is the endproduct of the hypothalamic-pituitary-adrenal (HPA) axis, one of the body’s major stress
response systems. HPA axis activity is regulated by the release of hypothalamic
corticotrophin-releasing hormone (CRH), which stimulates the synthesis and release of
adrenocorticotropic hormone (ACTH). Release of ACTH from the pituitary into the blood
stream triggers cortisol production and release from the adrenal cortex. Circulating cortisol
has effects on nearly every organ and tissue in the body (Munck, Guyre, & Holbrook, 1984).
During human pregnancy, regulation of the maternal HPA axis changes dramatically with
the synthesis of CRH from the placenta, beginning as early as the seventh week of gestation
(Davis & Sandman, 2010; McLean et al., 1995; Sandman & Glynn, 2009). In contrast to the
role of cortisol in the negative feedback regulation of the HPA axis, cortisol stimulates
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placental CRH production, resulting in a positive feedback loop that allows for the
simultaneous increase of CRH, ACTH, and cortisol in both the maternal and fetal
compartments (King, Nicholson, & Smith, 2001; Petraglia, Florio, Nappi, & Genazzani,
1996). Over the course of normal gestation, maternal cortisol increases two- to four-fold
(Mastorakos & Ilias, 2003; Sandman et al., 2006).

Author Manuscript

Fetal exposure to increasing concentrations of maternal cortisol is regulated by a placental
enzyme, 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), which oxidizes cortisol to
cortisone (Beitins, Bayard, Ances, Kowarski, & Migeon, 1973; Brown et al., 1996). Activity
of placental 11β-HSD2 increases throughout most of gestation, but because it is only a
partial barrier, some active maternal cortisol passes through the placenta, resulting in
significant concordance between cortisol levels in the maternal and fetal compartments
(Gitau, Cameron, Fisk, & Glover, 1998; Gitau, Fisk, Teixeira, Cameron, & Glover, 2001).
Prior to parturition, the activity of the 11β-HSD2 decreases, further increasing fetal exposure
to maternal cortisol (Giannopoulos, Jackson, & Tulchinsky, 1982; Murphy, Smith, Giles, &
Clifton, 2006). The normative increase in maternal cortisol during gestation coupled with the
decrease in placental 11β-HSD2 activity at the end of pregnancy ensures that the fetus is
exposed to sufficient levels of cortisol during the third trimester, which is important for
maturation of the fetal lungs and other organs (including the brain) and for preparation of the
fetus for labor and delivery (Austin & Leader, 2000; Hacking, Watkins, Fraser, Wolfe, &
Nolan, 2001). In addition, these late cortisol exposures have been characterized as
comprising a critical “switch” necessary for normal brain development (Matthews, 2000).
We have demonstrated that these heightened exposures late in gestation may be associated
with salutary effects on brain development (Davis, Head, Buss, & Sandman, 2017; Davis &
Sandman, 2010).

Author Manuscript

Altered HPA-axis function among mothers of children with ASD.

Author Manuscript

Our proposal that fetal exposure to dysregulated maternal cortisol trajectories may confer
risk for ASD is supported by the fact that aberrant HPA-axis functioning is observed among
mothers of individuals with ASD. For example, mothers of adolescents and adults with ASD
exhibit a profile of HPA hypoactivity characterized by a blunted cortisol awakening response
when compared to mothers of typically developing individuals (Fecteau et al., 2017; Seltzer
et al., 2010; Wong et al., 2012). Interestingly, this hyporesponsive profile may be more
pronounced among mothers of children with ASD compared to mothers of children with
other developmental disabilities. Dykens and Lambert (2013), using group-based trajectory
analyses, identified two distinctive diurnal cortisol profiles among mothers caring for
children with ASD and other developmental disabilities − typical and blunted. Eighty-nine
percent of the mothers of children with ASD fell into the group exhibiting the blunted
profile, whereas mothers of children with Down syndrome, Prader-Willi syndrome, and
William’s syndrome were roughly evenly distributed between the two trajectory groups (53
vs 47%). Because chronic stress has been implicated in dysregulated HPA-axis function
(Miller, Chen, & Zhou, 2007; Tsigos & Chrousos, 2002), the widely accepted interpretation
of these findings is that these altered maternal HPA profiles are a consequence of parenting a
child with a developmental disorder (Bitsika, Sharpley, Andronicos, & Agnew, 2017; Davis
& Carter, 2008; Rivard, Terroux, Parent-Boursier, & Mercier, 2014; Theule, Wiener,
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Tannock, & Jenkins, 2010). However, the existing literature has yet to consider the
possibility that maternal hypocortisolism may represent a biological profile that could confer
risk for ASD in offspring.

The Current Study

Author Manuscript

Here with a prospective longitudinal design in which maternal prenatal cortisol profiles
during gestation were characterized and ASD symptoms in a sample of 5-year old children
were assessed, we examine whether or not fetal exposures to maternal cortisol are associated
with child ASD symptoms. Further, because ASD is overrepresented among males (BaronCohen et al., 2011; Lai, Lombardo, Auyeung, Chakrabarti, & Baron-Cohen, 2015; Werling
& Geschwind, 2013), and sex differences exist in fetal responses to adversity (Bale, 2011,
2016; Manson, 2008; Sandman, Glynn, & Davis, 2013), including specifically to prenatal
GC exposures (Adibi et al., 2015; Bale & Epperson, 2015; Glynn & Sandman, 2012; Kim,
Bale, & Epperson, 2015; Sandman, Davis, Buss, & Glynn, 2011), we test whether the
relations between prenatal cortisol and ASD symptoms differ based on fetal sex.

Method
Study Overview
Study participants included mother-infant pairs from a longitudinal study of prenatal
psychobiological risk and development. Women with singleton pregnancies less than 16
gestational weeks were recruited from obstetric clinics and a large university medical center
in Southern California. Maternal cortisol was assessed 5 times during pregnancy and child
ASD symptoms were assessed at 5 years of age.

Author Manuscript

Participants

Author Manuscript

The sample comprised 84 mothers and their children (Mage = 5.13, 51.2% female). Initial
prenatal recruitment criteria included: singleton pregnancy, English speaking, non-smoker,
over 18 years of age, no use of steroid medication, and no evidence for drug or alcohol use
during pregnancy. Additional inclusion criteria for this study were that the child had reached
age 5 during the funded study period. Mothers gave informed consent for all aspects of the
protocol, which was approved by the Institutional Review Board. The mothers were 27
percent Latina, 50 percent non- Hispanic white, and 88 percent were married to or
cohabitating with the child’s father. Fifty percent of the children were first born and the
mean gestational age at birth was 39.4 weeks (range 35.3 – 42.6 weeks’ gestation).
Additional descriptive information for the study sample is shown in Table S1 of the
Supplemental Material available online.
Procedures
Maternal plasma samples were obtained for cortisol analysis at 15 (M = 15.47 ± 0.95), 19
(M = 19.56 ± 1.09), 25 (M = 25.71 ± 1.08), 31 (M = 31.16 ± 0.88), and 36+ (M = 36.81 ±
0.90) weeks’ gestation. Mothers completed the Social Communication Questionnaire when
children were 5 years of age. Maternal reports of ethnicity, age, educational level, income,
and marital status were collected by structured interview.
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Cortisol assessment.—Maternal blood samples (20 ml/draw) were withdrawn by
antecubital venipuncture into EDTA (purple top) vacutainers and then immediately chilled
on ice. Aprotinin (Sigma Chemical, St. Louis, MO) was added at 500 KlU/ml blood. The
mean sample collection time across study visits was 13:39 hours (range across gestational
visits: 13:32 to 13:40) and the mean standard deviation of collection time across visits was
85 minutes (range: 73 to 108 minutes). Samples were centrifuged at 2000 × g for 15 min,
decanted into polypropylene tubes, and stor2ed at −80°C until assayed.

Author Manuscript

Plasma cortisol levels were determined by a competitive binding solid-phase enzyme- linked
immunosorbent assay (IBL Immuno Biological Laboratories America, Minneapolis, MN)
with reported sensitivity of .22 μg/dl. Plasma samples (20 μl) and enzyme conjugate (200 μl)
were thoroughly mixed in antibody-coated microtiter wells and incubated at room
temperature for 60 minutes. Each well was then washed three times with wash solution (400
μl per well), followed by a 15-min incubation at room temperature with substrate solution
(100 μl). Absorbance units were measured at 450 nm within 10 minutes of adding stop
solution. This assay has less than 9% cross-reactivity with progesterone and less than 2%
cross-reactivity with other naturally-occurring steroid hormones (e.g., testosterone,
estradiol). All samples were assayed in duplicate. Interassay and intra-assay coefficients of
variance were less than 8% with a minimum detectable level of .25 μg/dl.

Author Manuscript

Assessment of autism spectrum disorder symptoms.—Child ASD symptoms
were assessed using the Social Communication Questionnaire (SCQ) Lifetime version, a
widely-used, validated parent-report questionnaire based on the Autism Diagnostic
Interview − Revised (ADI-R; Lord, Rutter, & Le Couteur, 1994). The ADI-R is one of the
“gold standard” instruments for use in the assessment of ASD. Because the ADI-R is timeconsuming, typically taking 1.5 to 2 hours, and requires a highly trained clinician, the SCQ
was developed for use as a brief screening tool. The SCQ Lifetime version consists of 40
binary-scaled questions that evaluate communication skills, social relating, and range of
interests in children. Item 1 is not scored but is used to determine whether the child has
enough language to evaluate abnormalities in language. Therefore, scores range from 0–39
and scores above the cutoff of 15 (sensitivity of 0.85 and specificity of 0.75) suggest the
individual is likely to have ASD or another neurodevelopmental condition (Rutter, 2003).

Author Manuscript

Studies examining the distribution of core features of ASD (communication, social
reciprocal interaction, and restricted/repetitive/stereotyped patterns of behavior) in general
populations demonstrate that the social deficits characteristic of ASD are common and the
distribution of these traits continuous (Baron-Cohen et al., 2001; Constantino & Todd, 2003;
Mulligan et al., 2009; Posserud et al., 2006; Spiker et al., 2002). For use in this study’s
general community sample, SCQ scores were treated as a continuous variable, an approach
which is consistent with current emphases on dimensionality and the view that symptombased approaches are necessary for clarifying definition and classification of mental
illnesses (e.g. NIMH Research Domain Criteria (RDoC) project; Calamari, Wiegartz, &
Janeck, 1999; Constantino, 2011; Cuthbert, 2014; Insel et al., 2010).
Determination of obstetric risk and birth phenotype.—Maternal and infant medical
records were reviewed to assess pregnancy complications, medication use during gestation
Clin Psychol Sci. Author manuscript; available in PMC 2021 March 22.
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and birth outcome. An obstetric risk score accounted for prenatal infection, pregnancyinduced hypertension, gestational diabetes, oligohydramnios, polyhydramnios, preterm
labor, vaginal bleeding, placenta previa, and anemia. A cumulative score assessing prenatal
obstetric risk was derived from the sum of all present risk variables (Hobel, 1982).
Gestational age at birth (GAB) was calculated using patient report of last menstrual period
and confirmed with early pregnancy ultrasound according to American Congress of
Obstetrician and Gynecologists guidelines (American Congress of Obstetricians and
Gynecologists, 2014).

Author Manuscript
Author Manuscript

Statistical analyses.—For primary analyses to assess cumulative fetal exposure to
maternal cortisol across gestation, an index of maternal prenatal cortisol levels was
calculated by averaging maternal cortisol levels from each of the five gestational
assessments. Because cortisol production is affected both by advancing gestation and by
diurnal rhythms, before averaging, cortisol values were residualized within collection
timepoint for gestational week and time of day of sample collection. A multiple linear
regression was performed to examine whether maternal prenatal cortisol levels were
associated with child ASD symptoms. Demographic (maternal age, maternal race/ethnicity,
cohabitation with the child’s father, socioeconomic status), pregnancy (obstetric risk,
gestational age at birth), and child (age, sex, birth order) variables were considered as
potential covariates (See Table S2 for bivariate correlations with maternal prenatal cortisol
and child ASD symptoms). Gestational age at birth, socioeconomic status and obstetric risk
were associated with child ASD symptoms at p < .10 and were therefore included in the
model. Given well-documented sex differences in the prevalence of ASD (Baron-Cohen,
Knickmeyer, & Belmonte, 2005; Baron-Cohen et al., 2011; Ingudomnukul, Baron-Cohen,
Wheelwright, & Knickmeyer, 2007; Knickmeyer & Baron-Cohen, 2006; Nakayama,
Takahashi, Wakabayashi, Oono, & Radford, 2007) and evidence for sex differences in fetal
programming (Bale, 2011, 2016; Clifton, 2010; Manson, 2008; Sandman et al., 2013), we
evaluated fetal sex as a potential moderator of the association between maternal prenatal
cortisol and child ASD symptoms.
Overall, medication use during gestation in the study sample was low and did not impact
study findings (See Supplement for details of these analyses).

Author Manuscript

Secondary analyses were then conducted to examine whether any associations between
maternal prenatal cortisol levels and child ASD symptoms detected in the regression model
were dependent on gestational timing. Multilevel modeling (MLM) techniques were utilized
to examine week-by-week associations between maternal prenatal cortisol levels and child
ASD symptoms (Raudenbush & Bryk, 2002). HLM offers several advantages over other
OLS statistical methods for the evaluation of variation over time. First, standard regression
or ANOVA models are limited to one component of variability, the deviation of the
individual from the group mean. In comparison, HLM also takes into account the withinperson variability assessed over time. Second, estimates of the lack of fit in modeling each
individual’s data are derived and the less reliable data are weighted less heavily. Third, HLM
produces robust estimates despite missing values for the repeated dependent measure. Cases
with complete data are weighted more heavily, but all cases are included in the estimation of
effects. Initial testing indicated that a quadratic model best fit maternal prenatal cortisol
Clin Psychol Sci. Author manuscript; available in PMC 2021 March 22.
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trajectories and that child ASD symptoms were not associated with linear or quadratic
change in maternal prenatal cortisol levels over gestation. Therefore, a series of two-level
models were computed to test differences in maternal prenatal cortisol levels (intercepts)
centered at 1-week intervals within the range of assessments available (15–37 weeks). Level
1 (time-variant, within-dyad) variables were maternal prenatal cortisol levels, gestational
week, gestational week squared, and time of day of sample collection. Level-2
(timeinvariant, between-dyad) variables were child ASD symptoms and covariates
(gestational age at birth, socioeconomic status, and obstetric risk).

Results

Author Manuscript

As expected, a repeated measures ANOVA indicated that maternal plasma cortisol levels
increased over the course of pregnancy (F(1, 71) = 127.88, p < .001). Average maternal
gestational cortisol levels did not differ as a function of fetal sex (t = −0.43 – 1.45, p = .15
− .67). Male (M = 6.73, SD = 3.58) and female (M = 6.47, SD = 4.18) children also did not
differ in their ASD symptom scores (t = −0.31, p = .76), which is consistent with the
literature examining distribution of these symptoms and traits in the general population
(Constantino, 2011; Constantino & Todd, 2003; Mulligan et al., 2009; Ruzich et al., 2015).
Three participants scored at the clinical cut point for this questionnaire (see Figure S1).
Further, one male child in the sample had received a clinical diagnosis of ASD and his SCQ
score was 27. Regression and MLM analyses reported here exclude this individual. See the
Supplemental Material available online for regression and MLM analyses that do include
this case.

Author Manuscript

Regression analyses did not reveal a main effect of maternal prenatal cortisol levels;
however, the interaction between prenatal maternal cortisol and child sex was statistically
significant (Table 1). As shown in Figure 1, lower prenatal maternal cortisol levels were
associated with higher levels of ASD symptoms in boys (slope = −0.45, t = −2.48, p = .01),
but not in girls (slope = 0.10, t = 0.71, p = .48).
Multilevel modeling indicated that the association between prenatal maternal cortisol levels
on ASD symptoms in boys did not differ as a function of gestational timing, with
statistically significant intercept differences present across gestation (Coefficient: −0.35, SE
= 0.13, t = −2.78, p = .01; see Figure 2).

Discussion

Author Manuscript

Here we document a link between exposure to lower levels of prenatal maternal cortisol and
increased manifestation of ASD symptoms in early childhood among boys. Consistent with
the majority of studies examining prenatal influences on ASD risk, these effects were not
observed among girls (Baron-Cohen et al., 2011; Harrington, Lee, Crum, Zimmerman, &
Hertz- Picciotto, 2014; Werling & Geschwind, 2013). These findings also are consistent
with a number of previous studies documenting hyporesponsive HPA-axis function among
mothers of individuals with ASD (Dykens & Lambert, 2013; Foody, James, & Leader, 2015;
Seltzer et al., 2010). Because chronic stress exposures contribute to altered HPA-axis
function (Kinlein, Wilson, & Karatsoreos, 2015; Miller et al., 2007; Naughton, Dinan, &
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Scott, 2014), it is not surprising that the prevailing interpretation of the hyporesponsive
profile exhibited by mothers of children with ASD is that it is due to the significant and
documented stress associated with caring for a child with a developmental disability (De
Andres-Garcia, Moya-Albiol, & Gonzalez-Bono, 2012; Dykens & Lambert, 2013; Fecteau
et al., 2017; Foody et al., 2015; Wong, Mailick, Greenberg, Hong, & Coe, 2014; Wong et al.,
2012). However, the findings presented here raise the possibility of an alternate explanation
specifically, that causality may run the other way, or at least not be solely due to the stress of
caregiving. It is important to note that we are not suggesting that among these mothers such
caregiving does not represent a significant stressor, nor that this chronic stressor does not
have the potential to influence the HPA-axis function, but rather that altered HPA-axis
function among these individuals also may represent a marker of offspring ASD risk worthy
of further consideration. In fact, given that there is significant stability in a woman’s
endocrine profile (including cortisol) across pregnancies (Fox, Sandman, Davis, & Glynn,
2015), it is possible, even likely, that this may be one contributing environmental factor that
promotes concordant sibling phenotypic development. More specifically, the findings here,
coupled with the intraindividual stability in gestational physiology (Fox et al., 2015), may
shed light on the observation that there is a higher recurrence risk for ASD among maternal
compared to paternal half siblings (Gr0nborg, Schendel, & Parner, 2013; Risch et al., 2014).

Author Manuscript

There are a number of theories that implicate prenatal steroid hormone exposures in the
etiology of ASD, with a predominate focus on the role of testosterone (Knickmeyer &
Baron-Cohen, 2006; Pfaff, Rapin, & Goldman, 2011; Rose’meyer, 2013; Whitaker-Azmitia
et al., 2014). We are aware of only one study that considered prenatal cortisol levels and risk
for ASD. Baron-Cohen et al. (2015) identified a latent steroidogenic factor in amniotic fluid,
derived from shared variance in progesterone, 17 α-hydroxy-progesterone, androstenedione,
testosterone and cortisol, which was elevated among pregnancies resulting in offspring with
ASD. Because individual hormone levels were not tested, it is not possible to discern the
unique contributions of cortisol to ASD risk in this cohort. However, our findings, coupled
with those of Baron-Cohen et al. (2015), confirm the value of examining prenatal hormone
exposures as predictors of ASD risk and support the premise that altered prenatal steroid
exposures may contribute to the etiology of ASD.

Author Manuscript

GCs play a critical role in normal brain development and exert persisting effects on lifespan
HPA axis function (Davis, Waffarn, & Sandman, 2011; Howland, Sandman, & Glynn, 2017;
Kapoor, Petropoulos, & Matthews, 2008; Matthews, 2002), which is one reason why they
have been widely proposed as a central mechanism for programming the fetus (Matthews,
2000; Trejo, Cuchillo, Machin, & Rua, 2000; Welberg & Seckl, 2001). Most regions of the
CNS rely on GCs for normal maturation (Challis et al., 2001), and GCs exert these effects by
initiating terminal maturation, remodeling axons and dendrites and affecting cell survival
(Gelman, Flores-Ramos, Lopez-Martinez, Fuentes, & Grajeda, 2015; Zunszain, Anacker,
Cattaneo, Carvalho, & Pariante, 2011). Further, late gestational GC exposures, which are
facilitated by the drop in 11β-HSD2, provide critical developmental ‘switching’ in the fetal
brain (Fowden, Li, & Forhead, 1998; Moisiadis & Matthews, 2014).
A prevalent hypothesis suggests that the overrepresentation of neurodevelopmental
disorders, including ASD, among males may be due in part to sex-specific differences in
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placental function (Bale, 2011; Davis & Pfaff, 2014; Gabory, Roseboom, Moore, Moore, &
Junien, 2013; Sandman et al., 2013). The placenta, a transient endocrine organ of fetal
origin, continually responds to changes in the maternal milieu, with dynamic implications
for the intrauterine environment. Placental tissue is sex specific, and sexually dimorphic
responses most likely operate through alterations in gene expression (Graves, 2010; OseiKumah, Smith, Jurisica, Caniggia, & Clifton, 2011), changes in energy mobilization and
oxygen transport (O’Connell, Moritz, Walker, & Dickinson, 2013) and inflammatory
responses (Clifton & Murphy, 2004; Reynolds, Vickers, Harrison, Segovia, & Gray, 2015).
Most directly relevant to the findings here, sex-specific placental responses to GCs have
been documented (Stark, Wright, & Clifton, 2009). In response to synthetic GC treatment
for preterm labor, female fetuses exhibit larger increases in placental 11P-HSD2 activity
compared to males. Male fetuses also may be more vulnerable to a relative lack of cortisol
because during the third trimester, testosterone concentrations are higher in male
pregnancies and this could inhibit binding of GCs to their receptors (Da Silva, 1999;
Simmons, France, Keelan, Song, & Knox, 1994).

Author Manuscript

Limitations
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It is widely accepted that autism has a significant genetic component and it is the case that
both mothers and individuals with ASD manifest dysregulated HPA-axis function (Dykens
& Lambert, 2013; Hill, Wagner, Shedlarski, & Sears, 1977; Marinovic-Curin et al., 2008;
Taylor & Corbett, 2014); therefore, we cannot rule out the possibility that our findings
reflect a shared genetic vulnerability rather than the consequences of prenatal GC exposures.
Further, and perhaps more interestingly, emerging research has documented synergistic
effects between certain genetic profiles and exposures to prenatal stress in determining ASD
risk (Hecht et al., 2016; Schaafsma et al., 2017). Our study focused narrowly on prenatal
GCs, and so did not allow consideration of important gene x environment interactions. The
relatively small sample size comprises a third limitation to the current study. However, our
confidence in the results of this prospective study is enhanced by the fact that in this sample
we document three associations that are consistent with other, more well-established
findings: 1) an association between a hyporesponsive maternal HPA-axis profile and ASD
among offspring (Dykens & Lambert, 2013; Foody et al., 2015; Seltzer et al., 2010), 2)
positive associations between adverse birth phenotype, obstetric risk conditions and ASD
symptoms (Atladottir et al., 2010; Schendel & Bhasin, 2008), and 3) observed sex
differences revealing a male vulnerability, which is consistent with both the empirical and
theoretical literature (Baron-Cohen et al., 2011; Werling & Geschwind, 2013). A fourth
limitation relates to our use of a parent-report screening instrument as the measure of ASD
symptoms. However, the use of a dimensional instrument to assess symptoms is consistent
with an RDoC approach and current views advocating the use of dimensional measures to
advance understanding of ASD (Calamari et al., 1999; Constantino, 2011; Cuthbert, 2014;
Insel et al., 2010). Further, the distribution of SCQ scores was normal and the observed
variation is consistent with what would be expected based on use of this and other similar
instruments administered in the general population (See Figure S1; Constantino & Todd,
2003; Hoekstra, Bartels, Verweij, & Boomsma, 2007; Mulligan et al., 2009; Posserud,
Lundervold, & Gillberg, 2009; Wigham, McConachie, Tandos, & Le Couteur, 2012).
Relatedly, the importance and relevance of these findings for ASD should be considered
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with caution in light of the fact that we tested our hypotheses in a general community
sample. Future research in clinical populations is required to confirm whether prenatal
cortisol exposures might contribute to the development of this disorder.
Implications

Author Manuscript

ASD is a heterogeneous condition, characterized by marked variability in clinical
presentation and biological and behavioral phenotypes (Amaral, 2011; Beversdorf &
Missouri Autism Summit, 2016; Ellegood et al., 2015; Loth, Murphy, & Spooren, 2016).
With respect to identification of biomarkers, this unique heterogeneity demands
identification of ASD subgroups that are more biologically homogeneous, a goal requiring
novel stratification approaches that are sensitive to developmental stages and timing of
exposures (Beversdorf & Missouri Autism Summit, 2016; Loth, Spooren, et al., 2016).
Taken together, our new findings suggest that it might prove fruitful to incorporate prenatal
GC exposures into approaches aimed at addressing the heterogeneity of this condition and
also have several broader implications for advancing understanding of the origins of ASD.
First, they are consistent with the premise that the prenatal period plays a role in determining
risk for ASD, and that sex differences in the prevalence of developmental disorders such as
ASD may be due in part to the sexually dimorphic placenta. Second, the fact that we
observed hyporesponsive HPA-axis profiles among the mothers prior to the birth of their
children, provides a plausible alternative view of existing literature documenting blunted
HPA-axis activity in parents of children with ASD. The observed hypocortisolemic profile in
these mothers may represent a risk factor that precedes the stress of caregiving for a child
with ASD and not solely a consequence of the stress of caregiving. Further, the findings
presented here suggest that additional focus should be on pathways related to HPA-axis
function as well as on the developmental origins of this pervasive developmental disorder.
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Figure 1.
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Association between average prenatal maternal plasma cortisol and child SCQ scores. The
graph on the left represents this correlation for male children (r = −.45, p = .003). The graph
on the right represents this correlation for female children (r = .06, p = .70). One male child
had an ASD diagnosis (left panel, red data point). Including this case in the analyses did not
alter the association between prenatal cortisol and SCQ scores among males (r = −.42, p
= .006). Correlations account for both gestational week of sample collection and for time of
day of collection.

Author Manuscript
Clin Psychol Sci. Author manuscript; available in PMC 2021 March 22.

Ram et al.

Page 20

Author Manuscript
Author Manuscript
Author Manuscript
Figure 2.
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Maternal gestational plasma cortisol profiles in pregnancies with male fetuses. Mothers of
boys with low SCQ scores exhibit lower levels of cortisol across pregnancy compared to
mothers of boys with high SCQ scores. Trajectories of upper and lower quartiles of male
child SCQ scores derived from the multilevel models are shown for illustrative purposes
only. All analyses were conducted with SCQ scores as a continuous outcome and with
adjustment for time of day of sample collection.
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Multiple regression model predicting child ASD symptoms
B (SE)

β

Gestational Age at Birth

−0.42 (0.30)

−.14

−.16

Obstetric Risk

1.26 (0.69)

†

.20

SES

−1.18 (0.43)

−.28**

−.30

Prenatal Cortisol

0.10 (0.13)

.10

.09

Child Sex

0.14 (0.77)

.02

.02

Prenatal Maternal Cortisol × Child Sex

−0.55 (0.21)

−.32*

−.28

Partial r

.19

Note: Child sex coded 0 = female. Prenatal cortisol was residualized for gestational week of collection and for time of day of collection.
†

p < .10
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*

p < .05

**
p < .01
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